Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.12952
Abstract: This study compared the efficacy and safety of lixisenatide with placebo as add‐on therapy to basal insulin (BI) in adults aged ≥70 years with type 2 diabetes (T2D), with or without moderate renal insufficiency. read more here.
Keywords: therapy basal; add therapy; safety lixisenatide; efficacy safety ... See more keywords